Medicare AdvantageCoverageMedium impact
MA11.023l, Hyaluronan Therapies for Osteoarthritis of the Knee
Independence Blue Cross·Orthopedics, Rheumatology, Sports Medicine +1 more·Medical Policy
Effective date
Dec 1, 2025
We identified it
Jun 19, 2026
Summary
Medicare Advantage has updated the medical necessity criteria and coding requirements for hyaluronan therapy injections used to treat knee osteoarthritis. This affects billing procedures and documentation requirements for these joint injection treatments.
Action Required
By December 1, 2025: Billing team must review and update coding procedures for hyaluronan knee injections per new Medicare Advantage requirements. Providers should verify updated medical necessity criteria are met before treatment and ensure proper documentation. Review encounter forms and billing software settings for hyaluronan therapy procedures to align with new policy guidelines.